SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


         Date of Report (date of earliest event reported): July 13, 2007

                                QUANTUM MRI, INC.
                                -----------------
             (Exact name of Registrant as specified in its charter)


          Washington                     0-31679               54-0231483
  ---------------------------------------------------------------------------
 (State or other jurisdiction      (Commission File No.)      (IRS Employer
      of incorporation)                                    Identification No.)


                                 4750 Paton St.
                         Vancouver, B.C., Canada V6L 2J1
               --------------------------------------------------
          (Address of principal executive offices, including Zip Code)


       Registrant's telephone number, including area code: (303) 506-1633
                                                          ---------------

                                       N/A
                ------------------------------------------------
          (Former name or former address if changed since last report)




<PAGE>


Item 4.02  Non-Reliance  on  Previously  Issued  Financial   Statements  or  a
           Related Audit Report or Completed Interim Review.

   During the year ended March 31, 2006 the Company issued 5,000,000 shares of
   its common stock to a consultant. Although prior to March 31, 2006 these
   shares were returned to the Company and cancelled, due to the failure of the
   consultant to provide the agreed upon services, the Company did not record
   the cancellation of these shares in its financial statements for the year
   ended March 31, 2006.

   On July 13, 2007 the Company was notified by Manning Elliott LLP, its
   independent accountant, that the Company would need to restate its financial
   statements for the year ended March 31, 2006 to properly reflect the
   cancellation of the 5,000,000 shares. Kelly Fielder, the Company's only
   director, did not discuss the cancellation of the 5,000,000 shares with
   Manning Elliott until July 2007.

   Accordingly, the Company has restated its financial statements as at March
   31, 2006 and for the year then ended to reflect the cancellation of 5,000,000
   shares of common stock at the fair value of $1,750,000 during fiscal 2006.
   The effect of the restatement was to decrease net loss by $1,750,000 for the
   year ended March 31, 2006, and for the period from June 7, 1989 (date of
   inception) to March 31, 2006. Net loss per share was decreased by $0.16 per
   share to $0.99 per share for the year ended March 31, 2006.

   The following tables show the effect of this restatement on the Company's
   Consolidated Balance Sheet, Consolidated Statement of Operations and
   Consolidated Statement of Cash Flows.

    a)  Consolidated Balance Sheet
                                                    As of March 31, 2006
                                                As        Adjustment      As
                                             Reported          $       Restated
                                                $                          $

    Stockholder's Deficit
    Common Stock                              12,691        (5,000)      7,691

    Additional Paid-in Capital             5,544,528    (1,745,000)  3,799,528

    Deficit Accumulated During the
     Exploration Stage                    (7,204,068)    1,750,000  (5,454,068)

    b)  Consolidated Statement of Operations


<PAGE>

                                              Accumulated from June 7, 1989
                                               (Date of Inception) to March
                                                        31, 2006
                                            ------------------------------------
                                            As Reported  Adjustment  As Restated
                                                  $          $            $
   Expenses
     Consulting                               1,958,615   (1,750,000)   208,615
   Total Expenses                             6,276,079   (1,750,000) 4,526,079
   Net Loss                                  (6,543,851)   1,750,000 (4,793,851)


                                                For the year ended March 31,
                                                            2006
                                            ------------------------------------
                                            As Reported  Adjustment  As Restated
                                                  $          $            $
   Expenses
     Consulting                              1,786,567   (1,750,000)     36,567
   Total Expenses                            4,506,078   (1,750,000)  2,756,078
     Net Loss                               (4,776,581)   1,750,000  (3,026,581)
   Net Loss Per Share - Basic and Diluted        (1.15)        0.16       (0.99)

c)  Consolidated Statement of Cash Flows

                                              Accumulated from June 7, 1989
                                           (Date of Inception) to March 31, 2006
                                            ------------------------------------
                                            As Reported  Adjustment  As Restated
                                                  $          $            $

   Operating Activities
   Net loss for the period                  (6,543,851)   1,750,000  (4,793,851)
        Stock-based compensation             4,080,521   (1,750,000)  2,330,521


                                            For the year ended March 31, 2006
                                            ------------------------------------
                                            As Reported  Adjustment  As Restated
                                                  $          $            $

   Operating Activities
   Net loss for the year                     (4,776,581)  1,750,000  (3,026,581)
        Stock-based compensation              3,980,521  (1,750,000)  2,230,521


<PAGE>


Item 9.01         Financial Statements and Exhibits


Exhibit #    Description
---------    -----------

     7       Letter from Company's independent auditors addressing the
             disclosures in Item 4.02 of this report.




<PAGE>


                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


Date:   August 10, 2007
                                          QUANTUM MRI, INC.


                                          By: /s/ Kelly Fielder
                                              --------------------------------
                                              Kelly Fielder, President
[{"type": "8-K", "sequence": "1", "filename": "form8kaug07.txt", "secsgml_size_bytes": 7182}]
{"company-data": {"conformed-name": "QUANTUM MRI, INC.", "cik": "0001123844", "assigned-sic": "7389", "irs-number": "540231483", "state-of-incorporation": "WA", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-31679", "film-number": "071048819"}, "business-address": {"street1": "568-2803 W 4TH AVE", "street2": "-", "city": "VANCOUVER BC", "state": "A1", "zip": "V6K 4P4", "phone": "604-222-8861"}, "mail-address": {"street1": "4750 PATON STREET", "street2": "-", "city": "VANCOUVER", "state": "A1", "zip": "V6L 2J1"}, "former-company": {"former-conformed-name": "TRAVELSHORTS COM INC", "date-changed": "20000914"}}
SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

         Date of Report (date of earliest event reported): July 13, 2007

                                QUANTUM MRI, INC.
                                -----------------
             (Exact name of Registrant as specified in its charter)

          Washington                     0-31679               54-0231483
  ---------------------------------------------------------------------------
 (State or other jurisdiction      (Commission File No.)      (IRS Employer
      of incorporation)                                    Identification No.)

                                 4750 Paton St.
                         Vancouver, B.C., Canada V6L 2J1
               --------------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (303) 506-1633
                                                          ---------------

                                       N/A
                ------------------------------------------------
          (Former name or former address if changed since last report)
Item 4.02  Non-Reliance  on  Previously  Issued  Financial   Statements  or  a
           Related Audit Report or Completed Interim Review.

   During the year ended March 31, 2006 the Company issued 5,000,000 shares of
   its common stock to a consultant. Although prior to March 31, 2006 these
   shares were returned to the Company and cancelled, due to the failure of the
   consultant to provide the agreed upon services, the Company did not record
   the cancellation of these shares in its financial statements for the year
   ended March 31, 2006.

   On July 13, 2007 the Company was notified by Manning Elliott LLP, its
   independent accountant, that the Company would need to restate its financial
   statements for the year ended March 31, 2006 to properly reflect the
   cancellation of the 5,000,000 shares. Kelly Fielder, the Company's only
   director, did not discuss the cancellation of the 5,000,000 shares with
   Manning Elliott until July 2007.

   Accordingly, the Company has restated its financial statements as at March
   31, 2006 and for the year then ended to reflect the cancellation of 5,000,000
   shares of common stock at the fair value of $1,750,000 during fiscal 2006.
   The effect of the restatement was to decrease net loss by $1,750,000 for the
   year ended March 31, 2006, and for the period from June 7, 1989 (date of
   inception) to March 31, 2006. Net loss per share was decreased by $0.16 per
   share to $0.99 per share for the year ended March 31, 2006.

   The following tables show the effect of this restatement on the Company's
   Consolidated Balance Sheet, Consolidated Statement of Operations and
   Consolidated Statement of Cash Flows.

    a)  Consolidated Balance Sheet
                                                    As of March 31, 2006
                                                As        Adjustment      As
                                             Reported          $       Restated
                                                $                          $

    Stockholder's Deficit
    Common Stock                              12,691        (5,000)      7,691

    Additional Paid-in Capital             5,544,528    (1,745,000)  3,799,528

    Deficit Accumulated During the
     Exploration Stage                    (7,204,068)    1,750,000  (5,454,068)

    b)  Consolidated Statement of Operations
Accumulated from June 7, 1989
                                               (Date of Inception) to March
                                                        31, 2006
                                            ------------------------------------
                                            As Reported  Adjustment  As Restated
                                                  $          $            $
   Expenses
     Consulting                               1,958,615   (1,750,000)   208,615
   Total Expenses                             6,276,079   (1,750,000) 4,526,079
   Net Loss                                  (6,543,851)   1,750,000 (4,793,851)

                                                For the year ended March 31,
                                                            2006
                                            ------------------------------------
                                            As Reported  Adjustment  As Restated
                                                  $          $            $
   Expenses
     Consulting                              1,786,567   (1,750,000)     36,567
   Total Expenses                            4,506,078   (1,750,000)  2,756,078
     Net Loss                               (4,776,581)   1,750,000  (3,026,581)
   Net Loss Per Share - Basic and Diluted        (1.15)        0.16       (0.99)

c)  Consolidated Statement of Cash Flows

                                              Accumulated from June 7, 1989
                                           (Date of Inception) to March 31, 2006
                                            ------------------------------------
                                            As Reported  Adjustment  As Restated
                                                  $          $            $

   Operating Activities
   Net loss for the period                  (6,543,851)   1,750,000  (4,793,851)
        Stock-based compensation             4,080,521   (1,750,000)  2,330,521

                                            For the year ended March 31, 2006
                                            ------------------------------------
                                            As Reported  Adjustment  As Restated
                                                  $          $            $

   Operating Activities
   Net loss for the year                     (4,776,581)  1,750,000  (3,026,581)
        Stock-based compensation              3,980,521  (1,750,000)  2,230,521
Item 9.01         Financial Statements and Exhibits

Exhibit #    Description
---------    -----------

     7       Letter from Company's independent auditors addressing the
             disclosures in Item 4.02 of this report.
SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:   August 10, 2007
                                          QUANTUM MRI, INC.

                                          By: /s/ Kelly Fielder
                                              --------------------------------
                                              Kelly Fielder, President